PLURI INC (PLUR) Stock Fundamental Analysis

NASDAQ:PLUR • US72942G2030

3.56 USD
+0.01 (+0.28%)
Last: Feb 13, 2026, 03:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, PLUR scores 2 out of 10 in our fundamental rating. PLUR was compared to 523 industry peers in the Biotechnology industry. PLUR may be in some trouble as it scores bad on both profitability and health. PLUR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • PLUR had negative earnings in the past year.
  • In the past year PLUR has reported a negative cash flow from operations.
  • In the past 5 years PLUR always reported negative net income.
  • PLUR had a negative operating cash flow in each of the past 5 years.
PLUR Yearly Net Income VS EBIT VS OCF VS FCFPLUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -66.97%, PLUR is not doing good in the industry: 61.38% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -66.97%
ROE N/A
ROIC N/A
ROA(3y)-56.03%
ROA(5y)-56.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PLUR Yearly ROA, ROE, ROICPLUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K -20K

1.3 Margins

  • PLUR has a better Gross Margin (42.91%) than 74.19% of its industry peers.
  • PLUR's Gross Margin has declined in the last couple of years.
  • PLUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.31%
PLUR Yearly Profit, Operating, Gross MarginsPLUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • PLUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PLUR has more shares outstanding than it did 1 year ago.
  • PLUR has more shares outstanding than it did 5 years ago.
  • PLUR has a worse debt/assets ratio than last year.
PLUR Yearly Shares OutstandingPLUR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
PLUR Yearly Total Debt VS Total AssetsPLUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -21.02, we must say that PLUR is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -21.02, PLUR is not doing good in the industry: 83.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.02
ROIC/WACCN/A
WACC7.14%
PLUR Yearly LT Debt VS Equity VS FCFPLUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • PLUR has a Current Ratio of 0.53. This is a bad value and indicates that PLUR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.53, PLUR is doing worse than 89.67% of the companies in the same industry.
  • PLUR has a Quick Ratio of 0.53. This is a bad value and indicates that PLUR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PLUR's Quick ratio of 0.53 is on the low side compared to the rest of the industry. PLUR is outperformed by 89.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
PLUR Yearly Current Assets VS Current LiabilitesPLUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.34% over the past year.
  • The Revenue has grown by 121.74% in the past year. This is a very strong growth!
  • The Revenue has been growing by 125.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)24.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.64%
Revenue 1Y (TTM)121.74%
Revenue growth 3Y78.73%
Revenue growth 5Y125.33%
Sales Q2Q%-3.07%

3.2 Future

  • PLUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.56% yearly.
  • Based on estimates for the next years, PLUR will show a very strong growth in Revenue. The Revenue will grow by 153.63% on average per year.
EPS Next Y12.2%
EPS Next 2Y17.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year63.28%
Revenue Next 2Y153.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PLUR Yearly Revenue VS EstimatesPLUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
PLUR Yearly EPS VS EstimatesPLUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PLUR. In the last year negative earnings were reported.
  • Also next year PLUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PLUR Price Earnings VS Forward Price EarningsPLUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PLUR Per share dataPLUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PLUR's earnings are expected to grow with 17.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.56%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PLUR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PLURI INC

NASDAQ:PLUR (2/13/2026, 3:12:37 PM)

3.56

+0.01 (+0.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners14.91%
Inst Owner Change-23.28%
Ins Owners9.86%
Ins Owner Change5.68%
Market Cap32.93M
Revenue(TTM)1.33M
Net Income(TTM)-22.55M
Analysts82.86
Price Target12.24 (243.82%)
Short Float %0.28%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.21%
Min EPS beat(2)-34.3%
Max EPS beat(2)13.88%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.95%
Min Revenue beat(2)-51.44%
Max Revenue beat(2)-2.45%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24.83
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.1
EYN/A
EPS(NY)-1.94
Fwd EYN/A
FCF(TTM)-2.28
FCFYN/A
OCF(TTM)-2.12
OCFYN/A
SpS0.14
BVpS-1.23
TBVpS-1.86
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.91%
FCFM N/A
ROA(3y)-56.03%
ROA(5y)-56.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.31%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 400.53%
Cap/Sales 115.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -21.02
F-Score3
WACC7.14%
ROIC/WACCN/A
Cap/Depr(3y)237.36%
Cap/Depr(5y)153.18%
Cap/Sales(3y)103.83%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.64%
EPS Next Y12.2%
EPS Next 2Y17.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)121.74%
Revenue growth 3Y78.73%
Revenue growth 5Y125.33%
Sales Q2Q%-3.07%
Revenue Next Year63.28%
Revenue Next 2Y153.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.25%
OCF growth 3YN/A
OCF growth 5YN/A

PLURI INC / PLUR FAQ

What is the ChartMill fundamental rating of PLURI INC (PLUR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PLUR.


Can you provide the valuation status for PLURI INC?

ChartMill assigns a valuation rating of 0 / 10 to PLURI INC (PLUR). This can be considered as Overvalued.


What is the profitability of PLUR stock?

PLURI INC (PLUR) has a profitability rating of 1 / 10.


What is the financial health of PLURI INC (PLUR) stock?

The financial health rating of PLURI INC (PLUR) is 0 / 10.